First quarter 2026. The Lab Medicine Update is a collaboration between the UVA Medical Laboratories and the UVA Medical Laboratory Committee. Feedback on the LMU? Contact Jim Harrison (james.harrison@virginia.edu).
Urine drug confirmation test updates ↑
Benzodiazepines confirmation. The drug midazolam will be removed from the result list. Alpha-hydroxymidazolam will still be reported and is a better indicator of midazolam use.
Barbiturates confirmation. The drugs secobarbital and pentobarbital will be removed from the result list. The panel will consist of the drugs butalbital and phenobarbital.
These changes are effective 1/15/2026. Please contact Lindsay Bazydlo (LAL2S@uvahealth.org), Medical Director of the Toxicology Laboratory, with any questions.
Acute hepatitis panel update ↑
To align laboratory test menus with our Community Health partners, an Acute Hepatitis Panel (LAB 6731) is being made available to all UVA providers. This Acute Hepatitis Panel includes:
- hepatitis A IgM antibodies
- hepatitis B core IgM antibodies
- hepatitis C antibodies
- hepatitis B surface antigen
Borderline and reactive hepatitis C antibody results will reflex to a viral load. Two samples must be submitted.